4
Changes in Ownership
Aprea Therapeutics, Inc. Filed Acc 0001104659-26-075279
Director acquired 3,135 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Pamukcu Rifat Director | 2026-06-16 | Grant or award | +3,135 | 8,581 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Pamukcu Rifat Director | 2026-06-16 | Grant or award · Stock Options (Right to Buy) | +12,555 | 12,555 | D: show line 2 in the form |
Loading xslF345X06/tm2618211-2_4seq1.xml…